查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492632

霍亂疫苗市場：按類型、管理方法、最終用戶、年齡層別分類 - 全球預測 2024-2030

Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

霍亂疫苗市場規模預計2023年為2.8642億美元，2024年達到3.0702億美元，預計2030年將達到4.6983億美元，複合年成長率為7.32%。

霍亂疫苗是生物製藥，旨在保護個人免受霍亂的侵害，霍亂是一種由霍亂弧菌引起的嚴重腹瀉疾病。這些疫苗會刺激人體的免疫反應，使其能夠在接觸霍亂弧菌後快速識別並抵抗霍亂弧菌。霍亂疫苗有兩種：口服疫苗和注射疫苗，每種疫苗的效果和免疫持續時間不同。由於全球前往霍亂流行地區的旅行增加，霍亂疫苗的使用大幅增加，增加了旅客採取預防措施的需要。此外，人們對全球衛生工作的認知和國際支持的提高也增加了對脆弱地區疫苗接種計劃的財政和後勤支援。然而，霍亂疫苗的推出面臨一些挑戰。在偏遠和資源匱乏地區分發和管理疫苗的物流挑戰阻礙了普及。此外，受年齡和是否存在預先存在的免疫力等因素影響，疫苗誘導的免疫力存在變異性，這使得不同人群中疫苗功效的測量變得複雜。儘管有這些挑戰，疫苗技術的進步，例如單劑量疫苗和溫度穩定製劑的開發，有可能顯著提高疫苗宣傳活動的實用性和有效性。此外，將霍亂疫苗接種計劃與其他公共衛生工作相結合可以加強整體疾病控制並促進受影響地區更永續的健康改善。

主要市場統計
基準年[2023] 2.8642億美元
預計年份 [2024] 30702萬美元
預測年份 [2030] 46983萬美元
複合年成長率（%） 7.32%

區域洞察

霍亂疫苗市場由公共衛生需求和社會經濟條件決定，並在世界不同地區表現出獨特的特徵。在美國，來自霍亂流行地區和某些移民社區的旅客對它有需求。此外，該地區強大的醫療保健和衛生系統也有利於霍亂疫苗接種計畫。在歐洲，霍亂疫苗主要提供給前往流行地區的旅客和軍事相關人員。中東和非洲的霍亂風險和發病率很高，主要是由於衛生條件不佳和清潔水供應不足，因此需要霍亂疫苗。在亞太地區，由於南亞和東南亞霍亂盛行率很高，因此對霍亂疫苗的需求很高。印度和孟加拉等國家深受霍亂影響，是該地區需求的主要驅動力。意識的提高和政府控制霍亂疫情的努力也支持了這些疫苗的穩定消費。

FPNV定位矩陣

FPNV 定位矩陣對於評估霍亂疫苗市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對霍亂疫苗市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對霍亂疫苗市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地霍亂病例增加
      • 政府支持霍亂疫苗接種的廣告宣傳活動
    • 抑制因素
      • 疫苗研發高成本、產品短缺問題
    • 機會
      • 重組 DNA 技術與細胞生產系統的進展
      • 霍亂疫苗包裝與儲存解決方案的創新
    • 任務
      • 全球缺乏熟練的醫療保健專業人員
  • 市場區隔分析
    • 類型：減毒疫苗的採用率很高，因為它們能夠刺激強烈的免疫反應
    • 最終用戶：政府免疫計畫越來越重要，重點是教育人們霍亂預防方法和疫苗接種的重要性。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章霍亂疫苗市場：依類型

  • 去活化疫苗
  • 減毒活疫苗

第7章 依給藥方式分類的霍亂疫苗市場

  • 注射疫苗
  • 口服疫苗

第8章霍亂疫苗市場：依最終用戶分類

  • 政府疫苗接種計劃
  • 醫院/診所

第9章霍亂疫苗市場：依年齡層

  • 成人
  • 孩子們

第10章美洲霍亂疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區霍亂疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的霍亂疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 霍亂疫苗接種策略技術轉移：IVI 與 Biological E. Limited 之間的合作
    • GC Biopharma 與 Eubiologics 就霍亂疫苗生產建立策略聯盟
    • TechInvention 與 Eubiologics 合作在印度推出創新霍亂疫苗包裝
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-5D693B46BD1B

[199 Pages Report] The Cholera Vaccines Market size was estimated at USD 286.42 million in 2023 and expected to reach USD 307.02 million in 2024, at a CAGR 7.32% to reach USD 469.83 million by 2030.

Cholera vaccines are biological preparations designed to protect individuals from cholera, a severe diarrheal illness caused by the Vibrio cholerae bacteria. These vaccines stimulate the body's immune response, enabling it to quickly recognize and combat the cholera bacteria if exposed. There are several types of cholera vaccines available, including both oral and injectable forms, each with varying degrees of effectiveness and duration of immunity. The use of cholera vaccines has expanded considerably owing to the global increase in travel to areas where cholera is endemic, which has heightened the need for preventive measures among travelers. Further, growing awareness and international support for global health initiatives have increased funding and logistical support for vaccination programs in vulnerable regions. However, the deployment of cholera vaccines faces several challenges. Logistical difficulties in distributing and administering vaccines in remote or resource-limited areas hinder widespread coverage. Additionally, the variability in vaccine-induced immunity, which can be influenced by factors such as age and the presence of pre-existing immunity, complicates the measurement of vaccine effectiveness in different populations. Despite these challenges, advances in vaccine technology, such as the development of single-dose vaccines or temperature-stable formulations, could significantly improve the practicality and effectiveness of vaccination campaigns. Moreover, integrating cholera vaccination programs with other public health initiatives could enhance overall disease control and promote more sustainable health improvements in affected regions.

KEY MARKET STATISTICS
Base Year [2023] USD 286.42 million
Estimated Year [2024] USD 307.02 million
Forecast Year [2030] USD 469.83 million
CAGR (%) 7.32%

Regional Insights

The cholera vaccine market exhibits distinct characteristics across various global regions, shaped by public health needs and socio-economic conditions. In America, there is demand among travelers and certain immigrant communities from cholera-endemic regions. Further, robust healthcare and sanitation systems across the region facilitate cholera vaccination programs. Europe has a significant adoption of cholera vaccines, majorly among travelers and military personnel deployed to endemic regions. The Middle East and Africa face higher risks and incidences of cholera, primarily attributed to poor sanitation and inadequate access to clean water, generating a need for cholera vaccines. Asia-Pacific observes a significant need for the cholera vaccine owing to higher prevalence rates in South and Southeast Asia. Countries such as India and Bangladesh are heavily impacted by cholera, largely driving the need in the region. The increasing awareness and government initiatives to control cholera outbreaks also support the steady consumption of these vaccines.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Cholera Vaccines Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising number of cholera cases across the globe
      • Supportive government promotional campaigns for cholera vaccination
    • Market Restraints
      • High cost of vaccine development coupled with issues of product shortages
    • Market Opportunities
      • Developments in recombinant DNA technology and cell-based production systems
      • Innovations in packaging and storage solutions for cholera vaccines
    • Market Challenges
      • Limited availability of skilled healthcare professionals worldwide
  • Market Segmentation Analysis
    • Type: Higher adoption of attenuated vaccines owing to their ability to stimulate strong immune responses
    • End User: Growing significance of Government vaccination programs, focusing on educating people about cholera prevention methods and the importance of vaccination
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cholera Vaccines Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cholera Vaccines Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Strategic Technology Transfer in Cholera Vaccination: A Partnership Between IVI and Biological E. Limited

South Korea's International Vaccine Institute (IVI) has initiated a technology transfer to Biological E. Limited (BE), an Indian vaccine and pharmaceutical company. This collaboration involves IVI providing BE with the necessary technical information, know-how, and materials to manufacture the simplified oral cholera vaccine (OCV-S) in India. This partnership intends to enhance the availability of affordable cholera vaccines for both the Indian market and globally. [Published On: 2024-03-21]

Strategic Collaboration for Cholera Vaccine Production between GC Biopharma and Eubiologics

GC Biopharma, a South Korean biopharmaceutical company, has entered into a memorandum of understanding with Eubiologics to collaboratively produce the oral cholera vaccine, Euvichol. Under this agreement, Eubiologics will manage the bulk manufacturing phase of the vaccine, while GC Biopharma will handle the packaging tasks, including the bottling of the vaccine into vials, ensuring a streamlined process for vaccine supply. [Published On: 2023-08-28]

TechInvention Introduces Innovative Cholera Vaccine Packaging in India with Eubiologics Partnership

Mumbai-based TechInvention Lifecare, in collaboration with South Korea's Eubiologics Co., has introduced Euvichol-Plus, an oral cholera vaccine encased in a low-density polyethylene (LDPE) unidose pack. This innovative packaging solution addresses several issues associated with traditional glass vials, including risks of breakage and challenges in storage, transportation, handling, and disposal. [Published On: 2023-05-12]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cholera Vaccines Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cholera Vaccines Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Beijing Minhai Biological Technology Co., Ltd., Bharat Biotech Ltd., Bio-Manguinhos, Biological E Ltd, BioVac by Ceva Sante Animale, Emergent BioSolutions Inc., GlaxoSmithKline plc, Haffkine Bio-Pharmaceutical Corporation Ltd, Incepta Pharmaceuticals Ltd., Merck & Co. Inc, Panacea Biotec Ltd, Sanofi S.A., SK Inc., Techinvention Lifecare Pvt. Ltd., and Valneva SE.

Market Segmentation & Coverage

This research report categorizes the Cholera Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Inactivated Vaccine
    • Live Attenuated Vaccine
  • Method of Administration
    • Injectable Vaccines
    • Oral Vaccines
  • End User
    • Government Vaccination Programs
    • Hospitals & Clinics
  • Age Group
    • Adults
    • Children
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cholera cases across the globe
      • 5.1.1.2. Supportive government promotional campaigns for cholera vaccination
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of vaccine development coupled with issues of product shortages
    • 5.1.3. Opportunities
      • 5.1.3.1. Developments in recombinant DNA technology and cell-based production systems
      • 5.1.3.2. Innovations in packaging and storage solutions for cholera vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled healthcare professionals worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Higher adoption of attenuated vaccines owing to their ability to stimulate strong immune responses
    • 5.2.2. End User: Growing significance of Government vaccination programs, focusing on educating people about cholera prevention methods and the importance of vaccination
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cholera Vaccines Market, by Type

  • 6.1. Introduction
  • 6.2. Inactivated Vaccine
  • 6.3. Live Attenuated Vaccine

7. Cholera Vaccines Market, by Method of Administration

  • 7.1. Introduction
  • 7.2. Injectable Vaccines
  • 7.3. Oral Vaccines

8. Cholera Vaccines Market, by End User

  • 8.1. Introduction
  • 8.2. Government Vaccination Programs
  • 8.3. Hospitals & Clinics

9. Cholera Vaccines Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adults
  • 9.3. Children

10. Americas Cholera Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cholera Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cholera Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Strategic Technology Transfer in Cholera Vaccination: A Partnership Between IVI and Biological E. Limited
    • 13.3.2. Strategic Collaboration for Cholera Vaccine Production between GC Biopharma and Eubiologics
    • 13.3.3. TechInvention Introduces Innovative Cholera Vaccine Packaging in India with Eubiologics Partnership
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CHOLERA VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. CHOLERA VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CHOLERA VACCINES MARKET DYNAMICS
  • FIGURE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHOLERA VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GOVERNMENT VACCINATION PROGRAMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GOVERNMENT VACCINATION PROGRAMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 101. CHINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. CHINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 109. INDIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. INDIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 117. INDONESIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. INDONESIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. INDONESIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 120. INDONESIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 125. JAPAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. JAPAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. JAPAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 128. JAPAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 133. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 136. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 144. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 149. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 152. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 160. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 165. TAIWAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. TAIWAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. TAIWAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 168. TAIWAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 173. THAILAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. THAILAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. THAILAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 176. THAILAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 181. VIETNAM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. VIETNAM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. VIETNAM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 184. VIETNAM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 199. DENMARK CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. DENMARK CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. DENMARK CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 202. DENMARK CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 207. EGYPT CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. EGYPT CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. EGYPT CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 210. EGYPT CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 215. FINLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. FINLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. FINLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 218. FINLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 223. FRANCE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. FRANCE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. FRANCE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 226. FRANCE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 231. GERMANY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. GERMANY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. GERMANY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 234. GERMANY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 239. ISRAEL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. ISRAEL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. ISRAEL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 242. ISRAEL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 247. ITALY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. ITALY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. ITALY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 250. ITALY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 255. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 258. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 263. NIGERIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. NIGERIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. NIGERIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 266. NIGERIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 271. NORWAY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. NORWAY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. NORWAY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 274. NORWAY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 279. POLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. POLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. POLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 282. POLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 287. QATAR CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. QATAR CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. QATAR CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 290. QATAR CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 295. RUSSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. RUSSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. RUSSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 298. RUSSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 303. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 306. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 311. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 314. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 319. SPAIN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. SPAIN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. SPAIN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 322. SPAIN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 327. SWEDEN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. SWEDEN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. SWEDEN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 330. SWEDEN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 331. SWEDEN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 332. SWEDEN CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 335. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 338. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 340. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 343. TURKEY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. TURKEY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. TURKEY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 346. TURKEY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 347. TURKEY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 348. TURKEY CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 351. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 352. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 353. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 362. U